Our team is a research group focused on innovative treatment and management solutions for neurodegenerative diseases, mainly Parkinson’s disease, initiated by the world’s leading clinical experts in brain neurology and others. The team is committed to researching disease management solutions for elderly patients with neurodegenerative diseases across the entire time and disease cycle through digital diagnosis and treatment, neuromodulation, artificial intelligence and 5G technology to achieve more portable, cost-effective, and humane real-time monitoring and disease management.
Research Members
Kailiang Wang
- Doctor of Neurosurgery in Beijing Tiantan Hospital, Capital Medical University. Joint postdoctoral training at the University of Florida College of Medicine.
- Current Neurosurgeon at Xuanwu Hospital.
- Apply for 16 granted patents, published more than 10 sci-fi articles.
- Rare medical-industrial and composite talents, with 10 years of experience in neuromodulation and brain-computer interface.
Piu Chan
- Professor, doctoral supervisor.
- Geriatric medicine director of Capital Medical University.
- Chairman of China Parkinson’s Alliance, Founder of the China and International Parkinson’s Disease Research Collaborative Group, Director of China Clinical Research Center for Geriatric Diseases.
- Leading figure and academic leader in Parkinson’s field in China, a Chinese expert with a strong global presence in the field of Parkinson’s disaster.
Wei Hu
- Professor, University of Florida College of Medicine, USA.
- Director, International Center, University of Florida College of Medicine, USA. Head of Internet Platform of Parkinson’s Disease Center.
- Vice Chairman of China Neuromodulation Consortium.
Project Sponsor
